Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Resignation of Company Secretary and Compliance officer of the Company w.e.f December 12, 2023.14-12-2023
Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Resignation of Company Secretary and Compliance officer of the Company w.e.f December 12, 2023.Orchid Pharma: Investec initiates coverage with 'buy', sees 23% upside 5 key reasons
Despite an over 86 percent gain in the stock in 2023 YTD, domestic brokerage house Investec sees pharma firm Orchid Pharma (ORCD) rising another 23 percent in the next 12 months. The brokerage has initiated coverage on the stock with a buy' call and a target price of 800.Hot Stocks: Brokerages on Orchid Pharma, D-Mart, NOCIL and Chola Investment
Investec maintained a buy rating on Orchid Pharma with a target price of Rs 800. The company is set for strong growth over the next 3 years. The new management continues to execute the turnaround strategy well. It sees a strong 35%+ EBITDA CAGR over FY23-26 for the base biz (ex-PLI).Orchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Meeting Updates
Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 - Meeting UpdatesOrchid Pharma Ltd rating updated by CARE Ratings Limited to CARE A-
The company's Q2 turnover was 199 crore, up from 165.2 crore in the same quarter last yearOrchid Pharma Ltd - 524372 - Announcement under Regulation 30 (LODR)-Credit Rating
Announcement under Regulation 30 of SEBI (LODR) Regulation, 2015 - Credit RatingOrchid Pharma Ltd - 524372 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhanuka Laboratories LtdOrchid Pharma stocks gain 2% as promoter sells 2.56% stake
Orchid Pharma's Promoter Dhanuka Laboratories sold 13 lakh equity shares or a 2.56 percent stake, in the company via open market transaction at an average price of Rs 571.28 per share.Orchid Pharma Ltd - 524372 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Scrutinizer Report and Voting Results - Postal Ballot